Johnson & Johnson has been treading water for the past six months, recording a small loss of 3.8% while holding steady at ...

Johnson & Johnson’s Q1 2025 earnings reveal growth in sales and EPS, boosted by MedTech and Pharma. Click for my updated look at JNJ and its most recent news.

We've spotted 1 possible red flag for Johnson & Johnson you should be aware of. NYSE:JNJ Revenue & Expenses Breakdown as at Apr 2025 AI is about to change healthcare. These 26 stocks are working ...